Skip to main content
. 2018 Dec 20;2018(12):CD012033. doi: 10.1002/14651858.CD012033.pub4

Karcioglu 2013.

Study characteristics
Methods Randomised, double‐blind, placebo control
Participants N = 40, gender of participants not presented in demographic data
Interventions Ketamine 1 mg/kg bolus IV at anaesthesia induction + 25 mcg/kg/min IV infusion until the end of surgery
Outcomes Pain intensity (VAS) reported at PACU discharge and at 24 h postoperatively. Analgesic consumption reported as proportion (%) of participants receiving analgesics. AEs
Surgery type Laparoscopic cholecystectomy
Group numbers after end of study (treatment/control) 17/20
Age of patient population (treatment/control) 38.6 ± 11.7
43.4 ± 12.1
Notes No mention of sponsorship or funding. The authors declare no conflicts of interest
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated random sequence
Allocation concealment (selection bias) Unclear risk Allocation concealment method not described
Blinding of participants and personnel (performance bias)
All outcomes Low risk Blinded personnel
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes Low risk 8% was withdrawn
Selective reporting (reporting bias) Low risk Predefined outcomes reported (three participants withdrawn from the ketamine group because of hypertension)
Size High risk 17 and 20 participants per treatment arm